Form 4/A for OPRX OptimizeRx Corp
Accepted 2024-04-22 00:00:00 ET · period of report 2023-10-11 · accession 0001628280-24-017023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-04-22 | 2023-10-11 | OPRX | Stelmakh Edward | CFO, COO | M - OptEx | $0.00 | +8,221 | 28.0K | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common | 2023-10-11 | M | A | 8,221 | $0.00 | 28,034 | D | — | — | (F1) This Form 4 as originally filed reported in Table I and Table II a vesting of a restricted stock unit on 10/11/2022. However, this transaction had been previously reported on March 30, 2023. Accordingly, it has been struck from this amended filing. (F2) On October 12, 2023, the Reporting Person inadvertently understated in Table I of Form 4 (the "Original Form 4") the number of shares acquired upon the vesting a restricted stock unit. The correct amount of shares disposed of in connection with such vesting was correctly reported in Table II of the Original Form 4. (F3) As a result of the understatement, the amount reported in the Reported Person's holdings following the reported transaction was also understated. This inadvertent understatement has been corrected in this line of the amended filing. This understatement also affected the holdings reported after subsequent transactions in the Original Form 4 and in subsequently filed Forms 4, but will be corrected in any Forms 4 filed after the date of this amended filing. |